http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2526371-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 |
filingDate | 2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0369c1a68b79fa4e37cbc56e81dd564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d434e80a6ba3ae8c2623e560bb578da |
publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2526371-A1 |
titleOfInvention | Methods for preparing 2-alkynyladenosine derivatives |
abstract | Disclosed are methods for preparing 2-alkynyladenosine derivatives of Formula (A): or a stereoisomer, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate or isomorphic crystalline form thereof, the method comprising the step ofcontacting 2-iodoadenosine-5'-N-ethyluronamide with a compound of Formula (B): wherein Z is -C(=O)OR or -CH20C(=O)R, where R is a C1 to C5 alkyl, preferably methyl. The methods are useful for preparing 2~-alkynyladenosine derivatives that are, in certain embodiments, adenosine receptor agonists. |
priorityDate | 2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 295.